{"task_id": "9b6635dce862a058", "source": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf (Part 198/464)", "text": "\nPre Operative Assessment (p. 422)\nLung Cancer\n187\n\n--- Page 209 ---\nMesothelioma\nNEJM 2005 353:15\nPATHOPHYSIOLOGY\nCLASSIFICATION BY HISTOLOGY\n\u0002\nEPITHELIOID\ntubulopapillary, glandular, or solid.\n50 60%\n\u0002\nSARCOMATOID\nspindle cells\n\u0002\nBIPHASIC\nmixed with both epithelioid and sarco\nmatoid features\nASBESTOS AND MESOTHELIOMA\naccounts for\napproximately\n80%\nof\nmesothelioma.\nRisk\nof\nmesothelioma is higher with amphiboles/blue asbes\ntos than chrysotile/white asbestos. Asbestos fibers\nmay irritate the pleura, sever or pierce the mitotic\nspindle of cells and disrupt mitosis, induce generation\nof iron related reactive oxygen species, and phos\nphorylate MAP kinases and ERK 1 and 2. Tumor\nusually starts from parietal pleura and invades locally\nRISK FACTORS\n\u0002\nFAMILY HISTORY\nrare\n\u0002\nENVIRONMENTAL\nasbestos, radiation\nCLINICAL FEATURES\nLOCOREGIONAL\npleural (pleural effusion, pleuritic\nchest pain, dyspnea, SVC obstruction), peritoneal\n(ascites, abdominal pain, bowel obstruction), pericar\ndial (pericardial effusion, tamponade)\nMETASTATIC\nmiliary spread, liver, lung, bone, and/\nor adrenal lesions\nCONSTITUTIONAL\nweight loss, anorexia, fatigue\nSTAGING\nTNM STAGING\nT stage\n\u0002 T1=invasion\nlimited\nto\nipsilateral\npleura\n(T1a=parietal pleura, T1b=parietal pleura with\nfocal visceral pleura involvement)\n\u0002 T2=invades ipsilateral visceral pleura diffusely,\nlung, or diaphragm\n\u0002 T3=invades ipsilateral endothoracic fascia, med\niastinal fat, soft tissues of chest wall (solitary),\npericardium (non transmural)\n\u0002 T4=invades contralateral pleura or lung by direct\nextension, soft tissues of chest wall (diffuse or multi\nfocal), rib, any mediastinal organs, diaphragm,\nspine, pericardium, myocardium, brachial plexus\nN stage\n\u0002 N1=ipsilateral bronchopulmonary or hilar LN\n\u0002 N2=ipsilateral mediastinal LN\n\u0002 N3=contralateral mediastinal internal mam\nmary, supraclavicular, or scalene LN\nM stage\n\u0002 M1=distant metastasis\nSTAGE GROUPINGS\nStage\nTNM @=any\nIA\nIB\nT1aN0M0\nT1bN0M0\nII\nT2N0M0\nIII\nT1 2N1 2M0, T3N0 2M0\nIV\nT4N@M0, T@N3M1, T@N@M1\nINVESTIGATIONS\nBASIC\n\u0002\nLABS\nCBCD, lytes, urea, Cr, AST, ALT, ALP, bili\n\u0002\nIMAGING\nCXR, CT chest/abd, or MRI chest\n\u0002\nBIOPSY\nthoracentesis (sens 33 84%, cytology is\nusually inadequate), thoracoscopy with pleural\nbiopsy\nSPECIAL\n\u0002\nSERUM\nMESOTHELIN-RELATED\nPROTEIN (SMRP)\nsens 75 84%\n\u0002 PET SCAN\nif surgical candidate\nPROGNOSTIC ISSUES\nADVERSE PROGNOSTIC FACTORS\nmale, poor per\nformance status, sarcomatoid subtype, leukocytosis,\nanemia, thrombocytosis, advanced stage, high PET\nratios\nPROGNOSIS\nstage I=16 months median survival,\n\u00053 adverse prognostic factors= <6 months median\nsurvival, stage II IV=10 months median survival\nMANAGEMENT\nSTAGE I, II (resectable disease)\nsurgery (extra\npleural pneumonectomy, debulking) is controver\nsial and of questionable benefit. It should be con\nsidered for highly selected patients (age <55,\nperformance status \u00041, stage I or II and epithelioid\nhistology) and only after a good response to\nneoadjuvant chemotherapy to be followed by\nadjuvant radiation. Otherwise, treat as unresect\nable disease\nSTAGE III, IV (unresectable disease)\npalliative\nchemotherapy (cisplatin pemetrexed with vita\nmin B12 and folic acid supplementation or cispla\ntin gemcitabine). Second line options include repeating\ncisplatin gemcitabine, cisplatin pemetrexed, and vinor\nelbine. Pleurodesis should be considered\nSTAGING (CONT\u2019D)\n188\nMesothelioma", "text_length": 3366, "metadata": {"source": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf (Part 198/464)", "type": "chunk", "chunk_index": 197, "total_chunks": 464, "uploaded_by": "admin@admin.com", "upload_date": "2025-12-11T18:40:09.518271", "document_uuid": "fda2cab4-cdd9-4015-af24-46fd62c86d94", "filename": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf", "category": "medical_pdf", "section": "body", "year": null, "outdated": false, "document_id": "fda2cab4-cdd9-4015-af24-46fd62c86d94"}, "created_at": "2025-12-11T18:40:09.519177", "status": "complete", "chunks_added": 2}